A series of cases of splenomegaly in children with anemia and peculiar bone changes, 1925. ,
Global epidemiology of haemoglobin disorders and derived service indicators, Bull World Health Organ, vol.86, pp.480-487, 2008. ,
The population genetics of the haemoglobinopathies, Baillières Clin Haematol, vol.6, pp.215-62, 1993. ,
Beta-thalassemia major: what is the situation in France?, Rev Prat, vol.59, pp.1048-50, 2009. ,
Rapport D'Activité Année 2010-1er semestre 2011. Centre de référence Maladies Rares des Thalassémies, 2011. ,
Updates of the HbVar database of human hemoglobin variants and thalassemia mutations, Nucleic Acids Res, vol.42, pp.1063-1072, 2014. ,
,
, Ann Biol Clin (Paris), vol.72, pp.639-68, 2014.
, Lancet Lond Engl, vol.379, issue.11, pp.60283-60286, 2012.
Bases moléculaires des syndromes thalassémiques et facteurs génétiques modulateurs de sévérité de la beta-thalassémie. Rev Méditerranéenne Génétique Hum, 2010. ,
Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias, Nat Rev Genet, vol.2, pp.245-55, 2001. ,
Beta-thalassemia, Orphanet J Rare Dis, vol.5, p.11, 2010. ,
Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine, Haematologica, vol.89, pp.1187-93, 2004. ,
Cardiac Complications in thalassemia major, Hemoglobin, vol.33, pp.81-87, 2009. ,
, ALD n° 10-Liste des actes et prestations sur les syndromes thalassémiques majeurs et intermédiaires, HAS, 2009.
Modern Medicine Battles an Ancient Disease, Am J Hematol, 2015. ,
Results of long-term iron-chelating therapy, Acta Haematol, vol.95, pp.26-36, 1996. ,
, Physiologie du rein et bases physiopathologiques des maladies rénales
Amino-acid tolerance curves and amino-aciduria in Cooley's and sickle-cell anaemias, J Clin Pathol, vol.12, pp.245-53, 1959. ,
, Agence nationale de sécurité du médicament et des produits de santé. Mise sur le marché d'EXJADE ® (deferasirox) : informations importantes sur le bon usage et la surveillance du traitement. Lettre destinée aux professionnels de santé, 2007.
Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox, Acta Haematol, vol.123, pp.148-52, 2010. ,
Early markers of renal dysfunction in patients with beta-thalassemia major, Pediatr Nephrol, vol.23, pp.971-977, 2008. ,
End stage renal disease in six patients with beta-thalassemia intermedia, Blood Cells Mol Dis, vol.51, pp.146-154, 2013. ,
Renal dysfunction in patients with thalassaemia, Br J Haematol, vol.153, pp.111-118, 2011. ,
Mechanisms of renal disease in ?-thalassemia, J Am Soc Nephrol, vol.23, pp.1299-302, 2012. ,
Renal aspects of thalassaemia a changing paradigm, Eur J Haematol, vol.89, pp.187-97, 2012. ,
Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study, Blood, vol.115, pp.1886-92, 2010. ,
, ALD n° 10-PNDS sur les syndromes thalassémiques majeurs et intermédiaires, HAS, 2008.
,
, Rev Prat, vol.64, pp.1132-1139, 2014.
Deferasirox-induced renal impairment in children: an increasing concern for pediatricians, Pediatr Nephrol Berl Ger, vol.27, pp.2115-2137, 2012. ,
Complications and treatment of patients with ?-thalassemia in France: results of the National Registry, Haematologica, vol.95, pp.724-733, 2010. ,
Renal function in patients with-thalassaemia major: a long-term follow-up study, Nephrol Dial Transplant, vol.27, pp.3547-51, 2012. ,
Renal function in transfusion-dependent pediatric beta-thalassemia major patients, Hematology, vol.16, pp.249-54, 2011. ,
Renal complications in transfusion-dependent beta thalassaemia, Blood Rev, vol.24, pp.239-283, 2010. ,
Acquired Proximal Renal Tubular Dysfunction in ?-Thalassemia Patients Treated With Deferasirox, J Pediatr Hematol Oncol, vol.32, pp.564-571, 2010. ,
Hyperchloremic Metabolic Acidosis Due to Deferasirox in a Patient with Beta Thalassemia Major, Ann Pharmacother, vol.44, pp.219-240, 2010. ,
Fanconi syndrome in a patient with ?thalassemia major after using deferasirox for 27 months: Fanconi syndrome and deferasirox, Transfusion (Paris), vol.51, pp.949-54, 2011. ,
Glomerular Hyperfiltration and Proteinuria in Transfusion-Independent Patients with ßThalassemia Intermedia, Nephron Clin Pract, vol.121, pp.136-179, 2012. ,
Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an agelinked event with different effects on some renal parameters, Ann Hematol, vol.93, pp.525-532, 2014. ,
Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: A retrospective study, Blood Cells Mol Dis, vol.49, pp.133-138, 2012. ,
Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population, J Pediatr, vol.131, pp.252-259, 1997. ,
Renal Function in Children Suffering from Sickle Cell Disease: Challenge of Early Detection in Highly Resource-Scarce Settings, PLoS ONE, vol.9, p.96561, 2014. ,
Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature, Clin J Am Soc Nephrol, vol.5, pp.756-61, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00597593
Urine biochemical markers of early renal dysfunction are associated with iron overload in betathalassaemia, Clin Lab Haematol, vol.25, pp.105-114, 2003. ,
Renal function in children with ?-thalassemia major and thalassemia intermedia, Pediatr Nephrol, vol.23, pp.1847-51, 2008. ,
Incidence of deferasiroxassociated renal tubular dysfunction in children and young adults with betathalassaemia, Br J Haematol, vol.167, pp.434-440, 2014. ,
Renal function in pediatric patients with beta-thalassemia major, Pediatr Nephrol, vol.15, pp.109-121, 2000. ,
Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy, Kidney Int, vol.46, pp.467-70, 1994. ,
Kidney function tests in children with beta-thalassemia minor in Zahedan, southeast of Iran, Iran J Kidney Dis, vol.5, pp.201-204, 2011. ,
Major beta-thalassemia, use of desferiexamine and renal proximal tubular damage, Bratisl Lekárske Listy, vol.112, pp.278-81, 2011. ,
Renal abnormalities in patients with sickle cell-beta thalassemia, J Nephrol, vol.10, pp.163-170, 1997. ,
Renal Functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study, Ital J Pediatr, vol.36, p.39, 2010. ,
DOI : 10.1186/1824-7288-36-39
URL : https://ijponline.biomedcentral.com/track/pdf/10.1186/1824-7288-36-39?site=ijponline.biomedcentral.com
Beta thalassemia major: the effect of age on glomerular filtration rate, Saudi J Kidney Dis Transplant, vol.22, pp.963-971, 2011. ,
Glomerular and tubular functions in children with different forms of beta thalassemia, Ren Fail, vol.2015, pp.1-5 ,
DOI : 10.3109/0886022x.2015.1077314
GFR in Patients with ?-Thalassemia Major, Clin J Am Soc Nephrol, vol.10, pp.1350-1356, 2015. ,
DOI : 10.2215/cjn.12181214
URL : https://cjasn.asnjournals.org/content/10/8/1350.full.pdf
Hematuria in patients with Beta-thalassemia major, Iran J Kidney Dis, vol.4, pp.133-139, 2010. ,
Renal tubular dysfunction in pediatric patients with beta-thalassemia major, Saudi J Kidney Dis Transplant Off Publ Saudi Cent Organ Transplant Saudi Arab, vol.22, pp.497-500, 2011. ,
Renal tubular dysfunction with nephrocalcinosis in a patient with beta thalassemia minor, Saudi J Kidney Dis Transplant, vol.19, pp.964-972, 2008. ,
Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fractures, Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA, vol.24, pp.1965-71, 2013. ,
DOI : 10.1007/s00198-012-2260-y
The role of oxidative stress in hemolytic anemia, Curr Mol Med, vol.8, pp.609-628, 2008. ,
Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure, J Am Soc Nephrol, vol.17, pp.17-25, 2006. ,
DOI : 10.1681/asn.2005070757
URL : http://jasn.asnjournals.org/content/17/1/17.full.pdf
Hemodynamics and organ blood flow in fetal sheep subjected to chronic anemia, Am J Physiol, vol.261, pp.1542-1550, 1991. ,
DOI : 10.1152/ajpregu.1991.261.6.r1542
Renal lesions and clinical findings in thalassemia major and other chronic anemias with hemosiderosis, Pediatr Pathol Affil Int Paediatr Pathol Assoc, vol.9, pp.479-500, 1989. ,
DOI : 10.3109/15513818909026908
Deferasirox for managing iron overload in people with thalassaemia, Cochrane Database Syst Rev, vol.2, p.7476, 2012. ,
DOI : 10.1002/14651858.cd007476
URL : http://www.zora.uzh.ch/id/eprint/143432/1/Bollig_Bassler_2017_Neo_USZ.pdf
Deferasirox nephrotoxicity-the knowns and unknowns, Nat Rev Nephrol, vol.10, pp.574-86, 2014. ,
, The European Medecines Agency, 2007.
Effects of deferasirox on renal function and renal epithelial cell death, Toxicol Lett, vol.203, pp.154-61, 2011. ,
Transport of iron chelators and chelates across MDCK cell monolayers: implications for iron excretion during chelation therapy, Int J Hematol, vol.91, pp.401-413, 2010. ,
Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa?, Pharm Res, vol.19, pp.773-782, 2002. ,
Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma, J Am Soc Nephrol, vol.10, pp.1159-69, 1999. ,
Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation, Biochim Biophys Acta, vol.1413, pp.99-107, 1999. ,
Ferroptosis: an iron-dependent form of nonapoptotic cell death, Cell, vol.149, pp.1060-72, 2012. ,
Complex II defect via downregulation of iron-sulfur subunit induces mitochondrial dysfunction and cell cycle delay in iron chelation-induced senescence-associated growth arrest, J Biol Chem, vol.278, pp.51577-86, 2003. ,
Iron Chelation by Deferoxamine Prevents Renal Interstitial Fibrosis in Mice with Unilateral Ureteral Obstruction, PLoS ONE, vol.9, 2014. ,
Applicability of estimating glomerular filtration rate equations in pediatric patients: comparison with a measured glomerular filtration rate by iohexol clearance, Transl Res J Lab Clin Med, vol.165, pp.437-482, 2015. ,
A new equation to estimate glomerular filtration rate, Ann Intern Med, vol.150, pp.604-616, 2009. ,
Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline, Ann Intern Med, vol.158, pp.825-855, 2013. ,
Documentation of renal glomerular and tubular impairment and glomerular hyperfiltration in multitransfused patients with beta thalassemia, Ann Hematol, 2015. ,
The teenager with asymptomatic proteinuria: think orthostatic first, Clin Pediatr, vol.50, pp.179-82, 2011. ,
Renal vein obstruction and orthostatic proteinuria: a review, Nephrol Dial Transplant, vol.26, pp.562-567, 2011. ,
The prognostic significance of proteinuria in young college students, Ann Intern Med, vol.66, pp.685-96, 1967. ,
T2-star (T2*) magnetic resonance imaging for assessment of kidney iron overload in thalassemic patients, Arch Iran Med, vol.15, pp.91-95, 2012. ,